Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NewAmsterdam Pharma Company N.V. Ordinary Shares
NAMS | US
29.72
USD-1.74
-5.53%
NAMS | US
Loading StockChartView...
About NewAmsterdam Pharma Company N.V. Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
29.72
Open
31.52
High
31.99
Low
29.51
NewAmsterdam Pharma Company N.V. a clinical-stage biopharmaceutical company develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib a next generation oral and low-dose cholesteryl ester transfer protein (CETP) inhibitor that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden the Netherlands.
View LessNAMS | US
Risk
57.2
Sharpe
1.21
Luna's Score
58/100
Recommendation
Hold
Luna says (NAMS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Midcap (2B - 10B USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
51.6%1 month
57.2%3 months
53.5%6 months
50.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.47
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
27.63
Ent. to rev.
175.59
PEG
-
Other Fundamentals
EBITDA
-208.63M
MarketCap
2.68B
MarketCap(USD)
2.68B
Div. yield
-
Op. margin
-2.31K
Erngs. growth
-
Rev. growth
32.70
Ret. on equity
-54.08
Short ratio
1.84
Short perc.
0.83
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
7.22
Range1M
7.66
Range3M
9.23
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.10
Price X volume
27.74M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.63 | 0.53 | Expensive |
| Ent. to Revenue | 175.59 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.47 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 53.46 | 72.80 | Lower Risk |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 2.68B | 3.66B | Emerging |
